Intelerad, Densitas Partner on AI-Powered Breast Cancer Screenings

Densitas, a leader in AI solutions for breast cancer screening, has partnered with Intelerad Medical Systems, a prominent medical imaging software and services provider, to advance AI-driven breast cancer screening. This collaboration enhances clinical decision-making, operational efficiency, cost reduction, and adherence to mammography quality standards. Densitas' intelliMammo, integrated with Intelerad's IntelePACS and PenRad systems, offers comprehensive breast imaging solutions. intelliMammo's AI capabilities generate breast density, mammography quality, and cancer risk assessments, supporting workflow improvement and compliance with regulatory standards. This partnership extends these benefits to 2,500 healthcare organizations within Intelerad's network, contributing to better breast cancer screening.